Genprex Inc (GNPX)
2.44
+0.08
(+3.39%)
USD |
NASDAQ |
May 03, 16:00
2.34
-0.10
(-4.10%)
After-Hours: 20:00
Genprex Price: 2.44 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 2.39 | 2.540 | 2.33 | 2.44 | 23000.00 |
May 02, 2024 | 2.350 | 2.38 | 2.273 | 2.36 | 17865.00 |
May 01, 2024 | 2.27 | 2.359 | 2.25 | 2.26 | 13316.00 |
Apr 30, 2024 | 2.31 | 2.455 | 2.21 | 2.27 | 13242.00 |
Apr 29, 2024 | 2.210 | 2.29 | 2.12 | 2.29 | 4409.00 |
Apr 26, 2024 | 2.17 | 2.329 | 2.09 | 2.21 | 23049.00 |
Apr 25, 2024 | 2.24 | 2.24 | 2.11 | 2.12 | 8625.00 |
Apr 24, 2024 | 2.27 | 2.32 | 2.13 | 2.21 | 19677.00 |
Apr 23, 2024 | 2.21 | 2.50 | 2.18 | 2.31 | 30298.00 |
Apr 22, 2024 | 2.29 | 2.38 | 2.12 | 2.163 | 19446.00 |
Apr 19, 2024 | 2.23 | 2.50 | 2.09 | 2.13 | 38192.00 |
Apr 18, 2024 | 2.27 | 2.27 | 2.18 | 2.219 | 17493.00 |
Apr 17, 2024 | 2.35 | 2.542 | 2.20 | 2.21 | 20749.00 |
Apr 16, 2024 | 2.39 | 2.45 | 2.27 | 2.30 | 20368.00 |
Apr 15, 2024 | 2.77 | 2.77 | 2.35 | 2.35 | 32896.00 |
Apr 12, 2024 | 2.78 | 2.870 | 2.65 | 2.68 | 20689.00 |
Apr 11, 2024 | 2.81 | 2.912 | 2.74 | 2.78 | 16842.00 |
Apr 10, 2024 | 3.03 | 3.03 | 2.73 | 2.88 | 49924.00 |
Apr 09, 2024 | 3.03 | 3.23 | 2.910 | 3.07 | 126928.0 |
Apr 08, 2024 | 3.106 | 3.24 | 2.94 | 2.96 | 21454.00 |
Apr 05, 2024 | 2.99 | 3.179 | 2.97 | 3.00 | 17583.00 |
Apr 04, 2024 | 3.15 | 3.18 | 2.96 | 2.99 | 44470.00 |
Apr 03, 2024 | 2.89 | 3.27 | 2.89 | 3.11 | 97702.00 |
Apr 02, 2024 | 2.80 | 3.00 | 2.721 | 2.84 | 56497.00 |
Apr 01, 2024 | 3.00 | 3.01 | 2.84 | 2.97 | 47187.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.12
Minimum
Apr 25 2024
306.80
Maximum
Feb 08 2021
75.91
Average
59.60
Median
Feb 04 2020
Price Benchmarks
Lifecore Biomedical Inc | 6.39 |
Jaguar Health Inc | 0.318 |
BioXcel Therapeutics Inc | 2.57 |
TFF Pharmaceuticals Inc | 2.03 |
4D Molecular Therapeutics Inc | 26.38 |
Price Related Metrics
Price to Book Value | 0.6285 |
Earnings Yield | -924.6% |
Market Cap | 4.661M |